The fatigue after infusion or transfusion pilot trial and feasibility study: A three-armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia
- PMID: 38149691
- DOI: 10.1111/trf.17621
The fatigue after infusion or transfusion pilot trial and feasibility study: A three-armed randomized pilot trial of intravenous iron and blood transfusion for the treatment of postpartum anemia
Abstract
Background: Evidence for the management of moderate-to-severe postpartum anemia is limited. A randomized trial is needed; recruitment may be challenging.
Study design and methods: Randomized pilot trial with feasibility surveys.
Inclusion: hemoglobin 65-79 g/L, ≤7 days of birth, hemodynamically stable.
Exclusion: ongoing heavy bleeding; already received, or contraindication to intravenous (IV)-iron or red blood cell transfusion (RBC-T). Intervention/control: IV-iron; RBC-T; or IV-iron and RBC-T.
Primary outcome: number of recruits; proportion of those approached; proportion considered potentially eligible.
Secondary outcomes: fatigue, depression, baby-feeding, and hemoglobin at 1, 6 and 12 weeks; ferritin at 6 and 12 weeks. Surveys explored attitudes to trial participation.
Results: Over 16 weeks and three sites, 26/34 (76%) women approached consented to trial participation, including eight (31%) Māori women. Of those potentially eligible, 26/167 (15.6%) consented to participate. Key participation enablers were altruism and study relevance. For clinicians and stakeholders the availability of research assistance was the key barrier/enabler. Between-group rates of fatigue and depression were similar. Although underpowered to address secondary outcomes, IV-iron and RBC-T compared with RBC-T were associated with higher hemoglobin concentrations at 6 (mean difference [MD] 11.7 g/L, 95% confidence interval [CI] 2.7-20.7) and 12 (MD 12.8 g/L, 95% CI 1.5-24.2) weeks, and higher ferritin concentrations at 6 weeks (MD 136.8 mcg/L, 95% CI 76.6-196.9).
Discussion: Willingness to participate supports feasibility for a future trial assessing the effectiveness of IV-iron and RBC-T for postpartum anemia. Dedicated research assistance will be critical to the success of an appropriately powered trial including women-centered outcomes.
Keywords: anemia; blood transfusion; breastfeeding; erythrocyte transfusion; fatigue; ferric compounds; hematinics; intravenous infusion; iron; iron deficiency; iron-deficiency anemia; postpartum period.
© 2023 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB.
Similar articles
-
Intravenous iron versus blood transfusion for postpartum anemia: a systematic review and meta-analysis.Syst Rev. 2024 Jan 2;13(1):9. doi: 10.1186/s13643-023-02400-4. Syst Rev. 2024. PMID: 38169415 Free PMC article.
-
Single-dose intravenous iron infusion versus red blood cell transfusion for the treatment of severe postpartum anaemia: a randomized controlled pilot study.Vox Sang. 2017 Feb;112(2):122-131. doi: 10.1111/vox.12475. Epub 2016 Dec 23. Vox Sang. 2017. PMID: 28010050 Clinical Trial.
-
Intravenous iron treatment in the puerperium.Dan Med J. 2018 Apr;65(4):B5471. Dan Med J. 2018. PMID: 29619936 Review.
-
Intravenous iron vs blood for acute post-partum anaemia (IIBAPPA): a prospective randomised trial.BMC Pregnancy Childbirth. 2017 Dec 19;17(1):424. doi: 10.1186/s12884-017-1596-x. BMC Pregnancy Childbirth. 2017. PMID: 29258541 Free PMC article. Clinical Trial.
-
Intravenous versus Oral Iron for Iron-Deficiency Anemia in Pregnancy (IVIDA): A Randomized Controlled Trial.Am J Perinatol. 2022 Jun;39(8):808-815. doi: 10.1055/s-0041-1740003. Epub 2021 Nov 28. Am J Perinatol. 2022. PMID: 34839481 Clinical Trial.
References
REFERENCES
-
- Pasricha SR, Colman K, Centeno-Tablante E, Garcia-Casal MN, Peña-Rosas JP. Revisiting WHO haemoglobin thresholds to define anaemia in clinical medicine and public health. Lancet Haematol. 2018;5(2):60-62.
-
- World Health Organisation (WHO). Global anaemia reduction efforts among women of reproductive age: impact, achievement of targets and the way forward for optimizing efforts. Geneva: WHO; 2020. Available from: https://www.who.int/publications/i/item/9789240012202
-
- Breymann C, Honegger C, Hösli I, Surbek D. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum. Arch Gynecol Obstet. 2017;296(6):1229-1234.
-
- Figueiredo A, Gomes-Filho IS, Silva RB, Pereira MG. Maternal anemia and iron deficiency anemia: similarities and singularities. Health Care Curr Rev. 2018;6(1):1-6.
-
- Calje E, Marriott J, Oyston C, Dixon L, Bloomfield F, Groom K. Postpartum anaemia in three New Zealand district health board regions: an observational study of incidence and management. Aust NZ J Obstet Gynaecol. 2023;63:178-186.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical